The company recently raised a $300 million funding round led by SoftBank’s second vision fund. It’s one of several digital health startups looking to address access to mental healthcare.
According to STAT News, Cityblock raised a $400 million funding round led by SoftBank. It plans to put the capital toward its goal of serving 10 million members by 2030.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
SoftBank’s second Vision Fund led the recent funding round. Pear plans to use it to accelerate reimbursement coverage for its three FDA-cleared products.
The six-year-old Google-backed company was founded by three MIT physicists and hopes to use its technology to make drug discovery faster and less cumbersome by combining physics, AI and cloud computing.
Biofourmis, a Boston-based company that makes software-based therapeutic platforms, raised $100 million in a series C round led by SoftBank’s second Vision Fund. The company currently has developed a digital therapeutic for heart failure patients with Novartis, and plans to expand into other clinical areas.
In healthcare, Softbank has invested in a number of mainly biotech-focused companies including Relay Therapeutics, Roivant Sciences and Zymergen.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
The company, founded by Vivek Ramaswamy, anticipates topline data from six Phase III trials next year. It raised $1.1 billion last year in a round led by SoftBank.
Judy Smythe, Bardia Akbari and Niv Caviar have been named as the company's chief operating officer, senior vice president of clinical operations and chief financial officer, respectively.